A new device for measurement of fibrin clot lysis: Application to the Euglobulin Clot Lysis Time

被引:27
|
作者
Zouaoui Boudjeltia K. [1 ]
Cauchie Ph. [1 ]
Remacle Cl. [3 ]
Guillaume M. [2 ]
Brohée D. [1 ]
Hubert J.L. [4 ]
Vanhaeverbeek M. [1 ]
机构
[1] Laboratoire Medecine Experimentale, Universite de Libre de Bruxelles, Hôpital A. Vésale, Montigny-le-Tilleul
[2] Departement de Cardiologie, Montigny-le-Tilleul
[3] Laboratoire de Biologie Cellulaire, Univ. Catholique de Louvain-La-Neuve, Louvain-La-Nueve
[4] EREM SA Company, Marcinelle
关键词
Efficiency Score; Fibrinogen Level; Venous Occlusion; Clot Lysis; Lysis Time;
D O I
10.1186/1472-6750-2-8
中图分类号
学科分类号
摘要
Background: Determination of clot lysis times on whole blood, diluted whole blood, plasma or plasma fraction has been used for many years to assess the overall activity of the fibrinolytic system. We designed a completely computerised semi-automatic 8-channel device for measurement and determination of fibrin clot lysis. The lysis time is evaluated by a mathematical analysis of the lysis curve and the results are expressed in minute (range: 5 to 9999). We have used this new device for Euglobulin Clot Lysis Time (ECLT) determination, which is the most common test used in laboratories to estimate plasma fibrinolytic capacity. Results: The correlation between ECLT and manual method is very tight : R = 0,99; p < 10-6. The efficiency scores of the method are <4% in intra-assay and <7% in inter-assay. It allows to achieve the tests on hyperlipaemic samples. This new device has been easily integrated in laboratory routine and allows to achieve several ECLT every day without disturbance of laboratory workflow. Conclusions: The routine use of this new device could be useful in various situations such as assessment in atherosclerosis and arteriosclerosis associated diseases, coagulation survey of liver transplantations, cardiovascular surgery or pharmacological research. It has already provided highly promising results in preliminary studies on the relation between fibrinolysis and cardiovascular risk factors. © 2002 Boudjeltia et al; licensee BioMed Central Ltd.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] IMPROVED METHOD FOR EUGLOBULIN CLOT LYSIS TIME
    LOWE, ML
    CANNON, DC
    [J]. CLINICAL BIOCHEMISTRY, 1975, 8 (03) : 206 - 212
  • [2] Determinants of the euglobulin clot lysis time and a comparison with the dilute whole blood clot lysis time.
    MacCallum, PK
    Cooper, JA
    Howarth, DJ
    Attfield, J
    Meade, TW
    Miller, GJ
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 : 95 - 95
  • [3] INFLUENCE OF STANOZOLOL ON EUGLOBULIN CLOT LYSIS
    GORMSEN, J
    WINTHER, K
    KNUDSEN, JB
    [J]. HAEMOSTASIS, 1984, 14 (01) : 35 - 35
  • [4] A new euglobulin clot lysis assay for global fibrinolysis
    Smith, AA
    Jacobson, LJ
    Miller, BI
    Hathaway, WE
    Manco-Johnson, MJ
    [J]. THROMBOSIS RESEARCH, 2003, 112 (5-6) : 329 - 337
  • [5] A NEW ELECTROMECHANICAL DEVICE FOR MEASUREMENT OF CLOT LYSIS TIMES
    FOLUS, SG
    KRAMER, DN
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1970, 54 (03) : 361 - &
  • [6] KINETICS OF FIBRIN CLOT LYSIS
    MERRILLS, RJ
    SHAW, JTB
    [J]. BIOCHEMICAL JOURNAL, 1968, 106 (01) : 101 - &
  • [7] KINETICS OF FIBRIN CLOT LYSIS
    JOHANNESSEN, M
    PETERSEN, LC
    [J]. THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1309 - 1309
  • [8] The euglobulin clot lysis time to assess the impact of nanoparticles on fibrinolysis
    Valentine Minet
    Lutfiye Alpan
    François Mullier
    Olivier Toussaint
    Stéphane Lucas
    Jean-Michel Dogné
    Julie Laloy
    [J]. Journal of Nanoparticle Research, 2015, 17
  • [9] Blood lipids and euglobulin clot lysis time in men and women
    Boudjeltia, KZ
    Cauchie, P
    Guillaume, M
    Vanhaeverbeek, M
    [J]. THROMBOSIS AND HAEMOSTASIS, 1999, : 326 - 326
  • [10] THE SHORTENING OF EUGLOBULIN CLOT LYSIS TIME BY CALCIUM-ION
    KOZIMA, Y
    URANO, T
    KOZIMA, K
    SERIZAWA, K
    TAKADA, Y
    TAKADA, A
    [J]. THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1265 - 1265